The role of new technologies in treating children and adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 8, Issue SUPPL. 6, 2007, Pages 72-79

  Shalitin, S ^a,b   Phillip, Moshe ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Continuous glucose monitoring; Insulin analogs; Insulin pump therapy; Telemedicine

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; RECOMBINANT HUMAN INSULIN;

ADOLESCENT; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CHILD; COGNITIVE DEFECT; CONTINUOUS INFUSION; DEVICE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; EDUCATION PROGRAM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INDWELLING CATHETER; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MEDICAL TECHNOLOGY; METABOLIC REGULATION; MICROANGIOPATHY; MORBIDITY; NEUROLOGIC DISEASE; PARENT; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; TELEMEDICINE;

ADOLESCENT; BIOMEDICAL TECHNOLOGY; BLOOD GLUCOSE SELF-MONITORING; CATHETERS, INDWELLING; CHILD; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; PATIENT EDUCATION AS TOPIC;

EID: 34548207359     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00279.x     Document Type: Review

References (40)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Holcombe JH, Brunelle R, Zalani S, Deeb LC. Comparative study of insulin lispro and regular insulin in prepubertal children with type 1 diabetes. Diabetes 1998: 47: A96.
3. Colino E, Lopez-Capape M, Golmayo L, Alvarez MA, Alonso M, Barrio R. Therapy with insulin glargine (Lantus ®) in toddlers, children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2005: 70: 1-7.
4. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 2004: 27: 2622-2627.
5. Hanas R. Reducing injection pain in children and adolescents with diabetes: A review of indwelling catheters. Pediatr Diabetes 2004: 5: 102-111.
6. Glaser NS, Iden SB, Green-Burgeson D et al. Benefits of an insulin dosage calculation device for adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1641-1651.
7. Danne T, Battelino T, Jarosz-Chobot P et al. The PedPump Study: A low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005: 54 (Suppl. 1): A453 (Abstract).
8. Ahern JA, Boland EA, Doane R et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002: 3: 10-15.
9. Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003: 16: 393-399.
10. Weinzimer SA, Ahern JH, Doyle EA et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: A follow-up report. Pediatrics 2004: 114: 1601-1605.
11. Nimri R, Weintrob N, Benzaquen H, Ofan R, Fayman G, Phillip M. Insulin pump therapy in youth with type 1 diabetes mellitus: A retrospective paired study. Pediatrics 2006: 117: 2126-2131.
12. Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics 2003: 112: 559-564.
13. Cohen D, Weintrob N, Benzaquen H, Galatzer A, Fayman G, Phillip M. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: A randomized open crossover trial. J Pediatr Endocrinol Metab 2003: 16: 1047-1050.
14. Jeha GS, Karaviti LP, Anderson B et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005: 7: 876-884.
15. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999: 22: 1779-1784.
16. Di Meglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380-384.
17. Shehadeh N, Battelino T, Galatzer A et al. Insulin pump therapy for 1-6 year old children with type 1 diabetes. Isr Med Assoc J 2004: 6: 284-286.
18. Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: A descriptive study. Pediatr Diabetes 2005: 6: 22-31.
19. Admon G, Weinstein Y, Falk B et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. EPediatrics 2005: 116: e348-e355.
20. Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 diabetes mellitus: A one centre experience. Diabetologia 1989: 32: 421-426.
21. Lee DM, Weinert SE, Miller EE. A study of forearm versus finger stick glucose monitoring. Diabetes Technol Ther 2003: 4: 13-23.
22. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population based sample of children and adolescents with IDDM. Diabetes Care 1997: 20: 22-25.
23. Gough DA, Armour JC. Development of the implantable glucose sensor: What are the prospects and why is it taking so long? Diabetes 1995: 44: 1005-1009.
24. The Diabetes Research in Children Network (Direc Net) Study Group. GlucoWatch ® G2™ Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther 2004: 6: 559-565.
25. Chase HP, Beck R, Tamborlane W et al. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005: 28: 1101-1106.
26. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. DiabeteS Technol Ther 2000: 2 (Suppl 1): s13-s18
27. The Diabetes Research in Children Network (Direc Net) Study Group. Accuracy of the modified continuous glucose monitoring system (CGMS ®) sensor in an outpatient setting: Results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther 2005: 7: 109-114.
28. Weintrob N, Schechter A, Benzaquen H et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs. continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 2004: 158: 677-684.
29. Deiss D, Bolinder J, Riveline JP et al. Improved glycemic control in patients with type 1 diabetes using REAL-Time continuous glucose monitoring (CGM). Diabetes Care 2006: 29: 2625-2631.
30. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000: 23: 208-214.
31. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2002: 2: 708-716.
32. Halvorson M, Carpenter S, Kaiserman K, Kaufman F. A pilot trial in pediatrics with the sensor-augmented pump: Combining real-time continuous glucose monitoring with the insulin pump. J Pediatr 2007: 150: 103-105.
33. Hovorka R, Chassin LJ, Wilinska ME. Closing the loop: The ADICOL experience. Diabetes Technol Ther 2004: 6: 307-318.
34. d'A nnunzio G, Bellazi R, Lariza C et al. Telemedicine in the management of young patients with number of links and protocol changes type 1 diabetes mellitus: A follow-up study. Acta Biomed 2003: 74 (Suppl. 1): 49-55.
35. Rami B, Popow C, Horn W, Waldhoer T, Schober E. Telemedical support to improve glycemic control in adolescents with type 1 diabetes mellitus. Eur J Pediatr 2006: 165: 701-705.
36. Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003: 26: 1475-1479.
37. Adkins JW, Storch EA, Lewin AB et al. Home-based behavioral health intervention: Use of a telehealth model to address poor adherence to type-1 diabetes medical regimens. Telemed J E Health 2006: 12: 370-372.
38. Franklin VL, Wilson AW, Butler RA, Greene SA. A predictive tool for the self-management of diabetes (Librae): Evaluation using a continuous glucose monitoring system. Diabet Med 2005: 23: 21-25.
39. Brown SJ, Lieberman DA, Germeny BA, Fan YC, Wilson DM, Pasta DJ. Educational video game for juvenile diabetes: Results of a controlled trial. Med Inform 1997: 22: 77-89.
40. Aoki N, Ohta S, Masuda H et al. Edutainment tools for initial education of type-1 diabetes mellitus: Initial diabetes education with fun. Medinfo 2004: 11: 855-859.